Home Advanced Accelerator Applications

Advanced Accelerator Applications

acquired
IPO
Developer of Targeted Radioligand Therapy and Precision Radioligand Imaging Agents

Basic Information

Advanced Accelerator Applications develops, manufactures, and commercializes drugs for targeted radioligand therapy and precision radioligand imaging. Our expertise is built on a tradition of over 15 years in the manufacturing and commercialization of a portfolio of PET and SPECT nuclear medicine imaging products, which are applicable to many indications in oncology, neurology, cardiology, as well as infectious and inflammatory diseases.
Advanced Accelerator Applications S.A.
Auvergne-Lon-Alpes,France
101~500 people
January 01, 2002
pharmacovigilance@adacap.com